FRINK Linked Data Fragments server

Matches in SemOpenAlex for { <https://semopenalex.org/work/W1991021570> ?p ?o ?g. }

• W1991021570 endingPage "112" @default.
• W1991021570 startingPage "108" @default.
• W1991021570 abstract "The perfect tocolytic agent, which is completely safe for both the mother and fetus and, which will inhibit uterine contractions and stop preterm labour in every case does not exist and the search continues. Recently, research into a new group of tocolytic agents (the oxytocic antagonists) has led to the introduction of a new licensed drug, atosiban. Since the early 1950s, modifications of the oxytocin molecule have resulted in many analogues and antagonists, though initially none emerged as potentially useful drugs. Further modifications resulted in full uterotonic antagonism in animal models before an analogue was found that inhibited vasopressin‐stimulated uterine contractions in non‐pregnant healthy women. In vitro and animal models suggested the molecule was fully antagonistic, although it was found to be only partially agonistic in women. Further developments led to two modified oxytocin molecules with higher receptor affinity for human myometrium, both of which lacked agonism in humans. The analogue, atosiban, was found to be more potent and so was chosen for clinical evaluation in dysmenorrhoea and preterm labour. The first clinical reports were open label, observational pilot studies. Randomised, double‐blind, phase II placebo‐controlled studies followed showing that atosiban was significantly more effective than placebo with very few side effects. Dose‐response studies and phase III studies in which study or placebo groups could use alternative tocolytic agents also suggested that atosiban was an effective tocolytic agent with very few adverse events. The recent worldwide comparative study of atosiban versus different beta‐agonists represents the largest and most strictly controlled study of tocolytics ever published. Atosiban was found to be at least as effective as the beta‐agonists as a tocolytic agent, but significantly less likely to result in maternal cardiovascular side effects or the need to discontinue therapy as a result of unacceptable side effects." @default.
• W1991021570 created "2016-06-24" @default.
• W1991021570 creator A5022874050 @default.
• W1991021570 date "2003-04-01" @default.
• W1991021570 modified "2023-10-18" @default.
• W1991021570 title "The development and introduction of anti‐oxytocic tocolytics" @default.
• W1991021570 cites W1876794067 @default.
• W1991021570 cites W1975427048 @default.
• W1991021570 cites W1975460092 @default.
• W1991021570 cites W1975489317 @default.
• W1991021570 cites W1989325575 @default.
• W1991021570 cites W2000399626 @default.
• W1991021570 cites W2014751879 @default.
• W1991021570 cites W2015946314 @default.
• W1991021570 cites W2026194872 @default.
• W1991021570 cites W2028082499 @default.
• W1991021570 cites W2037143193 @default.
• W1991021570 cites W2040237541 @default.
• W1991021570 cites W2046451219 @default.
• W1991021570 cites W2076346384 @default.
• W1991021570 cites W2084324077 @default.
• W1991021570 cites W2085288958 @default.
• W1991021570 cites W2090827283 @default.
• W1991021570 cites W2114374730 @default.
• W1991021570 cites W2136191276 @default.
• W1991021570 cites W2153749211 @default.
• W1991021570 cites W2333699902 @default.
• W1991021570 cites W4248096658 @default.
• W1991021570 doi "https://doi.org/10.1046/j.1471-0528.2003.00055.x" @default.
• W1991021570 hasPubMedId "https://pubmed.ncbi.nlm.nih.gov/12763125" @default.
• W1991021570 hasPublicationYear "2003" @default.
• W1991021570 type Work @default.
• W1991021570 sameAs 1991021570 @default.
• W1991021570 citedByCount "28" @default.
• W1991021570 countsByYear W19910215702014 @default.
• W1991021570 countsByYear W19910215702015 @default.
• W1991021570 countsByYear W19910215702017 @default.
• W1991021570 countsByYear W19910215702019 @default.
• W1991021570 countsByYear W19910215702020 @default.
• W1991021570 countsByYear W19910215702022 @default.
• W1991021570 crossrefType "journal-article" @default.
• W1991021570 hasAuthorship W1991021570A5022874050 @default.
• W1991021570 hasConcept C126322002 @default.
• W1991021570 hasConcept C142724271 @default.
• W1991021570 hasConcept C172680121 @default.
• W1991021570 hasConcept C181612422 @default.
• W1991021570 hasConcept C197934379 @default.
• W1991021570 hasConcept C204787440 @default.
• W1991021570 hasConcept C27081682 @default.
• W1991021570 hasConcept C2776176026 @default.
• W1991021570 hasConcept C2776561140 @default.
• W1991021570 hasConcept C2778164554 @default.
• W1991021570 hasConcept C2778375690 @default.
• W1991021570 hasConcept C2779066055 @default.
• W1991021570 hasConcept C2779234561 @default.
• W1991021570 hasConcept C2780056395 @default.
• W1991021570 hasConcept C2780931799 @default.
• W1991021570 hasConcept C2908881489 @default.
• W1991021570 hasConcept C3019152611 @default.
• W1991021570 hasConcept C46973012 @default.
• W1991021570 hasConcept C54355233 @default.
• W1991021570 hasConcept C71924100 @default.
• W1991021570 hasConcept C86803240 @default.
• W1991021570 hasConcept C98274493 @default.
• W1991021570 hasConceptScore W1991021570C126322002 @default.
• W1991021570 hasConceptScore W1991021570C142724271 @default.
• W1991021570 hasConceptScore W1991021570C172680121 @default.
• W1991021570 hasConceptScore W1991021570C181612422 @default.
• W1991021570 hasConceptScore W1991021570C197934379 @default.
• W1991021570 hasConceptScore W1991021570C204787440 @default.
• W1991021570 hasConceptScore W1991021570C27081682 @default.
• W1991021570 hasConceptScore W1991021570C2776176026 @default.
• W1991021570 hasConceptScore W1991021570C2776561140 @default.
• W1991021570 hasConceptScore W1991021570C2778164554 @default.
• W1991021570 hasConceptScore W1991021570C2778375690 @default.
• W1991021570 hasConceptScore W1991021570C2779066055 @default.
• W1991021570 hasConceptScore W1991021570C2779234561 @default.
• W1991021570 hasConceptScore W1991021570C2780056395 @default.
• W1991021570 hasConceptScore W1991021570C2780931799 @default.
• W1991021570 hasConceptScore W1991021570C2908881489 @default.
• W1991021570 hasConceptScore W1991021570C3019152611 @default.
• W1991021570 hasConceptScore W1991021570C46973012 @default.
• W1991021570 hasConceptScore W1991021570C54355233 @default.
• W1991021570 hasConceptScore W1991021570C71924100 @default.
• W1991021570 hasConceptScore W1991021570C86803240 @default.
• W1991021570 hasConceptScore W1991021570C98274493 @default.
• W1991021570 hasIssue "s20" @default.
• W1991021570 hasLocation W19910215701 @default.
• W1991021570 hasLocation W19910215702 @default.
• W1991021570 hasOpenAccess W1991021570 @default.
• W1991021570 hasPrimaryLocation W19910215701 @default.
• W1991021570 hasRelatedWork W162879287 @default.
• W1991021570 hasRelatedWork W1982158830 @default.
• W1991021570 hasRelatedWork W2038278929 @default.
• W1991021570 hasRelatedWork W2044463593 @default.
• W1991021570 hasRelatedWork W2048108714 @default.
• W1991021570 hasRelatedWork W2157527585 @default.
• W1991021570 hasRelatedWork W2313369125 @default.

• next